| Similar Articles |
|---|
 |
Chemistry World
November 27, 2013
Michael Gross |
MEDIC to kick-start personalised medicine revolution A sensor that can continuously monitor the concentration of a drug in the bloodstream is set to help personalized medicine take off.   |
Chemistry World
July 2010
Anna Lewcock |
Medicine made to measure Healthcare tailored to suit the genetic makeup of the patient is finally coming to fruition. |
Chemistry World
January 21, 2011
Jennifer Newton |
Early lung cancer diagnosis Patients with lung cancer have elevated levels of a specific protein in their blood that could be used as a biomarker for the disease, say scientists from South Korea. |
Scientific American
March 2009
Elaine Schattner |
A Chip against Cancer: Microfluidics Scrutinizes T Cells With just a blood sample, a device could determine whether cancer is about to spread or monitor the progress of treatment |
Chemistry World
April 21, 2011
David Barden |
RNA analysis raises hopes of early cancer diagnosis An improved method for diagnosing colorectal cancer without using invasive techniques has been developed by scientists in China. |
The Motley Fool
August 29, 2011
Brian Orelli |
Drug Approved for Few Patients -- but That's OK The age of personalized medicine is upon us. Earlier this month, the FDA approved Roche's melanoma drug Zelboraf for patients with a specific mutation in BRAF. And on Friday, the agency approved Pfizer's Xalkori for lung cancer patients that are ALK-positive. |
Fast Company
Christina Farr |
Bill Gates, Illumina To Fund $100M Blood Test For Cancer Bill Gates, Jeff Bezos's venture fund Bezos Expeditions, and Arch Venture Partners will also contribute to the venture. Grail will be based in San Francisco, and Illumina will retain majority control. |
Pharmaceutical Executive
July 1, 2011
Dickmeyer & Rosenbeck |
From Rut to Racetrack Can the pharmaceutical industry deliver on its objective to make cancer a curable, chronic condition? |
Chemistry World
November 13, 2012
Rachel Cooper |
Detecting cancer cells and parasites Scientists in Denmark have designed a new sensor to detect cells that over-express folate receptors, including cancer cells. The sensor consists of an electrochemical platform composed of graphene and peptide nanotubes with folic acid. |
Wired
August 2003
Jennifer Kahn |
The End of Cancer (As we Know it) Diagnosis. Chemotherapy. Radiation. Slow painful death. No more. A new era of cancer treatment is dawning. Meet three scientists who are using the revelations of the Human Genome Project to reshape medicine. |
Technology Research News
February 25, 2004 |
Nanowires spot DNA mutation Nanowire sensors could eventually be built into labs-on-a-chip that could be used for medical diagnostics and pathogen detection in the field, and for drug discovery. |
Chemistry World
June 12, 2013
Sarah Houlton |
No small success Chad Mirkin has been the driving force behind four spin-out nanotechnology companies, and has more than 850 patents to his name. Yet he describes himself as something of an accidental chemist. He is particularly proud of spherical nucleic acids. |
Chemistry World
April 1, 2011
Erica Wise |
DNA detection for rapid HIV diagnosis The diagnosis of HIV in developing countries could be quicker using a low cost device developed by US scientists. |
American Family Physician
April 15, 2002
Heather McNeill & Sarah Morgan |
Quantum Sufficit A quick, fingerprick blood test could be used to detect ovarian cancer... An ex-addict's worst enemy isn't the item of addiction itself, but rather the sights and sounds associated with it... Women are having more babies now than at any time in the past 30 years... etc. |
The Motley Fool
October 27, 2006
Jack Uldrich |
Nanotech and the War on Cancer New imaging advances in nanotechnology will help speed cancers' end. What does it mean for investors? |
Managed Care
March 2007
Martin Sipkoff |
Managing Cancer Treatment Begins Before Diagnosis Health plans are increasingly involved in promoting the lifestyle changes that help their members avoid cancer, and are increasingly involved in clinical trials if prevention fails. |
The Motley Fool
April 20, 2010
Jim Mueller |
Better, Targeted Drugs, Dead Ahead Personalized medicine is becoming a reality that will help patients, companies, and investors. |
HHMI Bulletin
Nov 2010 |
Fusion genes that drive solid tumors are a new target for cancer therapies The success of Gleevec and related drugs has inspired researchers to step up their hunt for the molecular defects underlying other cancers. |
Wired
Thomas Goetz |
Why Early Detection Is the Best Way to Beat Cancer By getting regular blood tests, doctors may be able to diagnose cancer early, giving the patient a 90 percent chance of survival. |
Chemistry World
July 22, 2013
Kirsty Muirhead |
Circulating cancer cells spiral towards separation A new biochip developed by researchers in Singapore can isolate tumor cells from blood samples, and may one day be an alternative to more invasive methods for tracking later stage cancers. |
Chemistry World
August 30, 2009
Nina Notman |
Nanoparticle breath test for lung cancer A sensor that can differentiate between the volatile organic compounds in the breath of lung cancer patients and those of healthy people has been developed by scientists in Israel. |
Chemistry World
June 15, 2007
Lionel Milgrom |
Electrochemical Screening for Anti-Cancer Drugs A test that predicts an individual cancer patient's response to different drugs is about to enter clinical trials, developers have announced. The chances of successful treatment will increase, they predict, while costs will decrease. |
Bio-IT World
June 17, 2004 |
Minority Report With Iressa, the AstraZeneca drug approved by the FDA last year, there is a small group, maybe 10 to 20 percent of lung cancer patients, who get an almost miraculous response. Mutations may explain patient responses to the drug. |
BusinessWeek
May 23, 2005
Catherine Arnst |
If It Works for Breast Cancer... Studies are under way to see if promising strategies used against breast cancer can be used to fight other killers, such as lung, colon, and prostate cancer. |
Chemistry World
June 4, 2015
Thadchajini Retneswaran |
Microfluidic approach to personalised cancer treatment US scientists have developed an innovative microfluidic assay that can accurately predict how patients with a certain type of blood cancer will respond to an anticancer drug. |
The Motley Fool
February 27, 2004
Alyce Lomax |
Genentech's Hope For the past two days, Genentech has been an example of what many investors hinge their hopes and dollars on. Yesterday's FDA approval of the company's groundbreaking cancer drug, Avastin, was the reason positive sentiment remained infectious today. |
BusinessWeek
September 5, 2005
Capell & Arndt |
Drugs Get Smart Future medicines will more effectively target what ails you by tailoring treatment to your specific genetic profile. Personalized medicine will also help prevent another Vioxx. |
Chemistry World
March 4, 2011
Elinor Richards |
Laser treatment for late-stage cancer Scientists from China, the US and Peru claim to have successfully treated late-stage breast cancer patients using laser immunotherapy to stimulate patients' own immune systems to fight the cancer. |
BusinessWeek
March 8, 2004
Arlene Weintraub |
And When ImClone's Drug Doesn't Work... Physicians have greeted ImClone Systems Inc.'s (IMCL ) cancer drug, Erbitux, with a mixture of glee and grim realism. The drug dramatically shrinks colon tumors in some patients. But in others, it has little effect -- and no one knows why. |
Fast Company
David Lumb |
Sites That Sell Cancer Gene Tests Don't Tell Customers The Whole Story, Study Finds Consumer tests that analyze DNA from tumors in order to help personalize a patient's treatment are in something of a Wild West period. |
AskMen.com
Harold Russell |
The Truth About Lung Cancer Read this article to find out about the causes, symptoms, treatments, and preventive measures of lung cancer. |
The Motley Fool
April 12, 2005
Brian Gorman |
Genentech's Cancer Quest The company's achievements in lung cancer further strengthen its reputation as a cancer fighter. Would-be investors are best served by waiting patiently. |
Popular Mechanics
June 2008
Elizabeth Svoboda |
10 High-Tech Health Breakthroughs Coming Soon to Your Body Scientists reveal their research on future medical technology devices and alternative medicine delivery systems. |
Technology Research News
July 30, 2003
Eric Smalley |
Chip senses trace DNA Handheld detectors could one day allow you to monitor your body for cancer, your water for chemicals, and your food for bacteria. This requires inexpensive electronics that are capable of detecting trace amounts of substances. One candidate is a chip containing DNA-tipped carbon nanotubes. |
Managed Care
June 2007
Thomas Morrow |
Dendritic Cell Vaccine Hits FDA Roadblock Questions about study design and analysis prompted the FDA to postpone action on Provenge, a treatment for advanced prostate cancer. |
Chemistry World
June 6, 2013
Jennifer Newton |
Power-free nucleic acid extraction device HIV RNA has been successfully extracted from human blood using a portable device that does not need electrical power to work. |
CIO
May 29, 2014
Stephanie Overby |
CIOs Join Forces to Battle Cancer A coalition of healthcare IT chiefs are on a mission to put cancer out of business and share IT best practices, technology tips, and personal support. |
BusinessWeek
June 6, 2005
Catherine Arnst |
Better Odds Against Breast Cancer New treatments for breast cancer are more effective, and easier to live with |
| AskMen.com |
Good Health Care News New advice from the American Cancer Society puts a sharper focus on the risks of prostate cancer screening, emphasizing that annual testing can lead to unnecessary biopsies and treatments that do more harm than good. |
Chemistry World
June 4, 2008
John Bonner |
Fireflies make light work of tumours Cancer researchers can see how effective new chemotherapy drugs are at destroying tumours by using the light that causes fireflies to glow in the dark. |
Chemistry World
June 9, 2008
Simon Hadlington |
Artificial virus silences genes Scientists in Korea have created an artificial virus that can target the nucleus of cancer cells and knock out specific genes. |
Chemistry World
July 28, 2006
Tom Westgate |
Radioactive Scorpion Venom Stings Brain Tumours Scorpion venom carries a nasty sting for brain tumour cells. A peptide based on chlorotoxin, found in the venom of the Giant Yellow Israeli Scorpion, has been used to target glioma, a particularly aggressive form of brain tumour. |
Bio-IT World
February 18, 2004 |
Pathology Goes Molecular New technologies are enabling clinical diagnostic laboratories to pave the way toward more personalized cancer therapies |
BusinessWeek
May 27, 2010
Pettypiece & Gibson |
Training the Immune System to Fight Cancer Bristol-Myers' new melanoma drug may be a "game changer." |
Scientific American
May 2009
Christine Soares |
Cancer Clues from Embryonic Development Rethinking cancer by seeing tumors as a cellular pregnancy. |
Chemistry World
January 12, 2015
Emma Stoye |
Protein mutant libraries to probe diseases' genetic link quickly and cheaply Researchers in the US have developed a faster and less costly way to investigate the effects of genetic mutations on proteins, which should offer new insights into hereditary diseases. |
American Family Physician
February 15, 2005 |
Health Care After Cancer Treatment An informative patient hand-out on follow-up cancer care. |
Chemistry World
August 31, 2011
Hayley Birch |
Smallpox vaccine virus puts cancer in its sights The results of a human cancer therapy trial show for the first time that tumors can be targeted and infected by engineered viruses, without damage to surrounding tissues. |
Technology Research News
October 6, 2004 |
Chip spots DNA electrochemically A microelectrochemical method of reading DNA chips could be used in portable detectors. It could be use practically in two to five years, according to the researchers. |
Bio-IT World
October 14, 2004
Robert M. Frederickson |
Nanosphere Strikes Gold Recently, scientists at Nanosphere developed a colorimetric method for DNA detection that obviates the need for target or signal amplification. |
